Abivax S.A annual operating margin
2021
2022
2023
2024
2025
Abivax S.A's operating margin was −5,384.16% for fiscal 2025.
View full Abivax S.A company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −5,384.16% | −3994.62 pp |
| 2024 | 2024-12-31 | −1,389.54% | +1366.92 pp |
| 2023 | 2023-12-31 | −2,756.46% | −1341.75 pp |
| 2022 | 2022-12-31 | −1,414.71% | −1068.58 pp |
| 2021 | 2021-12-31 | −346.12% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −16,283.64% | −15290.87 pp |
| Q3 2025 | 2025-09-30 | −3,950.66% | −159.95 pp |
| Q2 2025 | 2025-06-30 | −4,253.98% | −3626.30 pp |
| Q1 2025 | 2025-03-31 | −4,748.49% | −981.96 pp |
| Q4 2024 | 2024-12-31 | −992.76% | — |
| Q3 2024 | 2024-09-30 | −3,790.71% | — |
| Q2 2024 | 2024-06-30 | −627.68% | — |
| Q1 2024 | 2024-03-31 | −3,766.53% | — |
Across the available reported history, Abivax S.A's operating margin decreased from −1,389.54% to −5,384.16%, a change of −3994.62 percentage points. The latest reported quarter, Q4 2025, shows −16,283.64%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abivax S.A filings at SEC.gov ↗